Belite Bio Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Belite Bio stock has a consensus rating of "Strong Buy" and an average price target of $227.44. The average 1-year stock price forecast is 33.82% higher than the current stock price, while the lowest is $185 (+8.85%) and the highest is $303 (+78.28%).

Price Target: $227.44 (+33.82%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$185	$227.44	$217	$303
Change	+8.85%	+33.82%	+27.68%	+78.28%

Analyst Ratings

The average analyst rating for Belite Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	6	6	6	6	7	7
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Graig Suvannavejh Mizuho Securities	Mizuho Securities	Buy Maintains $234 → $221	Buy	Maintains	$234 → $221	+30.03%	Oct 29, 2026
Yi Chen H.C. Wainwright	H.C. Wainwright	Buy Reiterates $245	Buy	Reiterates	$245	+44.15%	Oct 15, 2026
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Buy Initiates $303	Buy	Initiates	$303	+78.28%	Sep 4, 2026
Tazeen Ahmad Bank of America Securities	Bank of America Securities	Buy Maintains $200	Buy	Maintains	$200	+17.67%	Sep 3, 2026
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Maintains $201 → $206	Buy	Maintains	$201 → $206	+21.20%	Aug 17, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

274.23M

EPS This Year

-2.94

from -2.31

EPS Next Year

2.26

from -2.94

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	-
Operating Income	-9.80M	-12.82M	-31.67M	-40.00M	-84.21M	-145.68M
Net Income	-9.67M	-12.65M	-31.63M	-36.14M	-77.61M	-128.93M
EPS	-	-	-	-	-2.31	-2.94
Free Cash Flow	-	-	-	-	-37.06M	-54.40M
No. Analysts	-	-	-	-	-	8

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.30
Avg	-2.94
Low	-3.97

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-